Citation Impact
Citing Papers
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
Prognostic Factors in Non-small Cell Lung Cancer
2002
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?
1998
The 2004 World Health Organization classification of lung tumors
2005 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
2009 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Palliative radiotherapy regimens for non-small cell lung cancer
2001
Lung Cancer
2008 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome
2006
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial
1996
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Lung Cancer: Epidemiology, Etiology, and Prevention
2011 Standout
The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis
1997
Molecular mechanisms of cisplatin resistance
2011 Standout
ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinase
2006
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
1997
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
2010
Cellular processing of platinum anticancer drugs
2005 Standout
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Sarcoidosis
1997 Standout
Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer
2004
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
1997
ZD0473 treatment in lung cancer: an overview of the clinical trial results
2002
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
ROS and the DNA damage response in cancer
2018 Standout
Platinum drugs in the treatment of non-small-cell lung cancer
2002
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results
2000
Slaying RAS with a synthetic lethal weapon
2010 StandoutNobel
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer
2004
Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis
1993
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
2010
Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)
2012
Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: A Preliminary Report of a Phase I Dose Escalation Trial from the Carolina Conformal Therapy Consortium
2001
p53 and HER2/neu Expression in Relation to Chemotherapy Response in Patients with Non-Small Cell Lung Cancer
2006
Combination therapy in combating cancer
2017 Standout
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
1999
γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
2014
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of Samir Darwish being referenced
Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer
2002
Plasma DNA, Microsatellite Alterations, and p53 Tumor Mutations Are Associated with Disease-Free Survival in Radically Resected Non-small Cell Lung Cancer Patients: A Study of the Perugia Multidisciplinary Team for Thoracic Oncology
2008
Helper Inducer T Cells in the Lungs of Sarcoidosis Patients
1989
A randomized trial of three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group
1990
Biological prognostic factors for early stage completely resected non-small cell lung cancer
2000
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma
2003
Short-Course Palliative Radiotherapy in Non–Small-Cell Lung Cancer
2000
Induction therapy for NSCLC: a consensus report
1991
Induction therapy for Stage III NSCLC: A consensus report
1994
Biological Markers and DNA Flow Cytometric Analysis in Radically Resected Patients with Non-Small Cell Lung Cancer. A Study of the Perugia Multidisciplinary Team for Thoracic Tumors
2008